Literature DB >> 29799649

Implementation of an Opioid Detoxification Management Pathway Reduces Emergency Department Length of Stay.

Shawna D Bellew1, Sean P Collins1, Tyler W Barrett1, Stephan E Russ1, Ian D Jones1, Corey M Slovis1, Wesley H Self1.   

Abstract

OBJECTIVES: With the rise of opioid use in the United States, the increasing demand for treatment for opioid use disorders presents both a challenge and an opportunity to develop new care pathways for emergency department (ED) patients seeking opioid detoxification. We set out to improve the care of patients presenting to our ED seeking opioid detoxification by implementing a standardized management pathway and to measure the effects of this intervention.
METHODS: We conducted a before-after study of the effects of an opioid detoxification management pathway on ED length of stay (EDLOS), use of resources (social worker consultation, laboratory tests obtained), and return visits to the same ED within 30 days of discharge. All data were collected retrospectively by review of the electronic health record.
RESULTS: Ultimately, 107 patients presented to the ED that met criteria, 52 in the intervention period and 55 in the preintervention period. Median EDLOS in the intervention period was 152 (interquartile range [IQR] = 93-237) minutes compared to 312 (IQR = 187-468) minutes in the preintervention period (p < 0.001). Patients in the intervention period less frequently had a social work consultation (32.7% vs. 83.6%, p < 0.001) or had laboratory tests obtained (32.7% vs 74.5%, p < 0.001) and more frequently were prescribed a medication for withdrawal symptoms (57.7% vs. 29.1%, p = 0.003).
CONCLUSIONS: Implementation of an opioid detoxification management pathway reduced EDLOS, reduced utilization of resources, and increased the proportion of patients prescribed medications for symptom relief.
© 2018 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2018        PMID: 29799649      PMCID: PMC6185770          DOI: 10.1111/acem.13457

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   5.221


  12 in total

1.  Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.

Authors:  Michael D Stein; Mitika Kanabar; Bradley J Anderson; Anna Lembke; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2016-06-16

2.  Do α2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal?

Authors:  Michael Gottlieb; Katarzyna Gore
Journal:  Ann Emerg Med       Date:  2016-11-04       Impact factor: 5.721

3.  Implementation of a Risk Stratification and Management Pathway for Acute Chest Pain in the Emergency Department.

Authors:  Christopher W Baugh; Jeffrey O Greenberg; Simon A Mahler; Joshua M Kosowsky; Jeremiah D Schuur; Siddharth Parmar; George R Ciociolo; Christina W Carr; Roya Ghazinouri; Benjamin M Scirica
Journal:  Crit Pathw Cardiol       Date:  2016-12

4.  Adherence to an Accelerated Diagnostic Protocol for Chest Pain: Secondary Analysis of the HEART Pathway Randomized Trial.

Authors:  Simon A Mahler; Robert F Riley; Gregory B Russell; Brian C Hiestand; James W Hoekstra; Cedric W Lefebvre; Bret A Nicks; David M Cline; Kim L Askew; John Bringolf; Stephanie B Elliott; David M Herrington; Gregory L Burke; Chadwick D Miller
Journal:  Acad Emerg Med       Date:  2015-12-31       Impact factor: 3.451

Review 5.  Update on Barriers to Pharmacotherapy for Opioid Use Disorders.

Authors:  Anjalee Sharma; Sharon M Kelly; Shannon Gwin Mitchell; Jan Gryczynski; Kevin E O'Grady; Robert P Schwartz
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

6.  High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.

Authors:  Pedro Mateu-Gelabert; Lauren Jessell; Elizabeth Goodbody; Dongah Kim; Krista Gile; Jennifer Teubl; Cassandra Syckes; Kelly Ruggles; Jeffrey Lazar; Sam Friedman; Honoria Guarino
Journal:  Int J Drug Policy       Date:  2017-05-31

Review 7.  Alpha₂-adrenergic agonists for the management of opioid withdrawal.

Authors:  Linda Gowing; Michael Farrell; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2016-05-03

Review 8.  Polydrug abuse: a review of opioid and benzodiazepine combination use.

Authors:  Jermaine D Jones; Shanthi Mogali; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-08-02       Impact factor: 4.492

9.  What happens when the doctor denies a patient's request? A qualitative interview study among general practitioners in Norway.

Authors:  Stein Nilsen; Kirsti Malterud
Journal:  Scand J Prim Health Care       Date:  2017-06-05       Impact factor: 2.581

Review 10.  Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities.

Authors:  Dennis McCarty; Kelsey C Priest; P Todd Korthuis
Journal:  Annu Rev Public Health       Date:  2017-12-22       Impact factor: 21.981

View more
  2 in total

Review 1.  Methodological Approaches to Support Process Improvement in Emergency Departments: A Systematic Review.

Authors:  Miguel Angel Ortíz-Barrios; Juan-José Alfaro-Saíz
Journal:  Int J Environ Res Public Health       Date:  2020-04-13       Impact factor: 3.390

2.  Effectiveness of the implementation of pediatric intussusception clinical pathway: A pre- and postintervention trial.

Authors:  So Hyun Paek; Do Kyun Kim; Young Ho Kwak; Jae Yun Jung; Seuk Lee; Joong Wan Park
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.